Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway.
Oncol Lett. 2021 Mar;21(3):219. doi: 10.3892/ol.2021.12480. Epub 2021 Jan 21.
Oncol Lett. 2021.
PMID: 33613708
Free PMC article.